casein kinase 1 inhibitors (ICOS)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecasein kinase 1 inhibitors (ICOS)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIcos Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIcos Corp
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A